M

Mediar Therapeutics

29 employees

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2019

Funding rounds raised

Total raised

$85M

from 7 investors over 7 rounds

M

Mediar Therapeutics raised $85M on March 15, 2023

Investors: Pureos Bioventures, Gimv, Mission BioCapital, Bristol-Myers Squibb, UK and Sofinnova Partners

M

Mediar Therapeutics raised undisclosed on March 17, 2021

Investors: Mission BioCapital and Agent Capital

FAQ